Anti-cancer agent comprising protein c inhibitor

作者: Koji Suzuki

DOI:

关键词:

摘要: The present invention provides anti-cancer agents comprising protein C inhibitor (PCI) or derivatives thereof as an active ingredient. of the have activities suppressing cancer cell growth, and metastasis, infiltration, angiogenesis. Further, has shown that containing a heparin-binding domain PCI inhibit metastasis angiogenesis cells. Therefore, according to invention, are useful for inhibiting cancer.

参考文章(38)
Tracy P. Jackson, Scott T. Cooper, Frank C. Church, Assessment of the interaction between urokinase and reactive site mutants of protein C inhibitor. Journal of Protein Chemistry. ,vol. 16, pp. 819- 828 ,(1997) , 10.1023/A:1026324102618
Marc G.L.M. Elisen, Peter A.Kr. von dem Borne, Bonno N. Bouma, Joost C.M. Meijers, Protein C Inhibitor Acts as a Procoagulant by Inhibiting the Thrombomodulin-Induced Activation of Protein C in Human Plasma Blood. ,vol. 91, pp. 1542- 1547 ,(1998) , 10.1182/BLOOD.V91.5.1542
Koji Suzuki, Protein C inhibitor. Methods in Enzymology. ,vol. 222, pp. 385- 399 ,(1993) , 10.1016/0076-6879(93)22025-B
Marie Ranson, Clive Leighton Bunn, Barry John Allen, PAI-2 conjugates for the treatment and imaging of cancer ,(2001)
David N. Krag, Stephanie C. Pero, Lyn Oligino, Methods and compositions for inhibiting GRB7 ,(2001)
Jerzy Jankun, Ewa Skrzypczak-Jankun, Joanna Chorostowska-Wynimko, Steven H. Selman, Rafal Swiercz, Modified plasminogen activator inhibitor type-1 and methods based thereon ,(2003)
R A Shirk, M G Elisen, J C Meijers, F C Church, ROLE OF THE H HELIX IN HEPARIN BINDING TO PROTEIN C INHIBITOR Journal of Biological Chemistry. ,vol. 269, pp. 28690- 28695 ,(1994) , 10.1016/S0021-9258(19)61960-5